Åke Borg
Principal investigator
Divergent mutational processes distinguish hypoxic and normoxic tumours
Author
Other contributions
- Åke Borg
- Markus Ringnér
- Johan Staaf
Summary, in English
Many primary tumours have low levels of molecular oxygen (hypoxia), and hypoxic tumours respond poorly to therapy. Pan-cancer molecular hallmarks of tumour hypoxia remain poorly understood, with limited comprehension of its associations with specific mutational processes, non-coding driver genes and evolutionary features. Here, as part of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium, which aggregated whole genome sequencing data from 2658 cancers across 38 tumour types, we quantify hypoxia in 1188 tumours spanning 27 cancer types. Elevated hypoxia associates with increased mutational load across cancer types, irrespective of underlying mutational class. The proportion of mutations attributed to several mutational signatures of unknown aetiology directly associates with the level of hypoxia, suggesting underlying mutational processes for these signatures. At the gene level, driver mutations in TP53, MYC and PTEN are enriched in hypoxic tumours, and mutations in PTEN interact with hypoxia to direct tumour evolutionary trajectories. Overall, hypoxia plays a critical role in shaping the genomic and evolutionary landscapes of cancer.
Department/s
- LUCC: Lund University Cancer Centre
- Familial Breast Cancer
- Breastcancer-genetics
- Molecular Cell Biology
- Breast/lungcancer
- Research Group Lung Cancer
Publishing year
2020-02-05
Language
English
Publication/Series
Nature Communications
Volume
11
Document type
Journal article
Publisher
Nature Publishing Group
Topic
- Medical Genetics
Keywords
- Cell Hypoxia/genetics
- Genes, myc
- Genome, Human
- Genomic Structural Variation
- Humans
- Mutation
- Neoplasms/genetics
- PTEN Phosphohydrolase/genetics
- Polymorphism, Single Nucleotide
- Tumor Hypoxia/genetics
- Tumor Microenvironment/genetics
- Tumor Suppressor Protein p53/genetics
- Whole Genome Sequencing
Status
Published
Research group
- Familial Breast Cancer
- Research Group Lung Cancer
ISBN/ISSN/Other
- ISSN: 2041-1723